Drug intelligence / Profile preview

Contrakel

Development stage: Unknown
Lead developer: Pharmadab
Modality: Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Contrakel is a topical scar care cream developed and manufactured by Pharmadab. It is classified as a medical device intended for the treatment and prevention of hypertrophic and atrophic scars, as well as keloids resulting from surgery, burns, acne, frostbite, or other injuries. The formulation contains a combination of active ingredients including vitamin A, urea, cholesterol, and allantoin. It works through a multi-level mechanism: providing a protective film to increase skin moisture content, promoting skin regeneration, and facilitating gentle massage to improve blood flow and soften scar tissue.

Brand names: Contrakel

Beyond the preview

Go deeper on Contrakel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contrakel.

Explore the full profile